161 related articles for article (PubMed ID: 3070529)
1. Immunological effects of adoptive immunotherapy with IL-2: an overview.
Kradin R; Yamin R; Kurnick J
Pathol Immunopathol Res; 1988; 7(6):434-41. PubMed ID: 3070529
[No Abstract] [Full Text] [Related]
2. The adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2.
Ettinghausen SE; Rosenberg SA
Springer Semin Immunopathol; 1986; 9(1):51-71. PubMed ID: 3523804
[No Abstract] [Full Text] [Related]
3. Adoptive therapies: quo vadis?
Clark JW; Longo DL
Pathol Immunopathol Res; 1988; 7(6):442-58. PubMed ID: 3070530
[TBL] [Abstract][Full Text] [Related]
4. Development of new immunologic approaches to cancer therapy.
Rosenberg SA
Blood Purif; 1988; 6(2):69-76. PubMed ID: 3293619
[TBL] [Abstract][Full Text] [Related]
5. "Lymphokine activated killing" as treatment for human cancer: clinical extrapolations from laboratory studies with interleukin-2 expanded leukocytes.
Sondel PM; Hank JA; Kohler PC; Chen BP; Sosman J
Prog Clin Biol Res; 1989; 288():151-60. PubMed ID: 2654949
[No Abstract] [Full Text] [Related]
6. [Interleukin-2 and cancer immunotherapy].
Ogarkov VI; Dobkin AI; Ryzhova EV; Okulov VB; Kiselev OI
Vopr Onkol; 1989; 35(2):141-50. PubMed ID: 2648678
[No Abstract] [Full Text] [Related]
7. Adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2.
Rosenberg SA
Important Adv Oncol; 1986; ():55-91. PubMed ID: 3330541
[No Abstract] [Full Text] [Related]
8. Natural killer cells and tumor immunity: 1987.
Hiserodt JC; Herberman RB
Year Immunol; 1989; 4():201-7. PubMed ID: 2648702
[No Abstract] [Full Text] [Related]
9. Adoptive immunotherapy in gastrointestine malignancies using interleukin-2. Current results and future prospects.
Marshall GD
Acta Chir Scand Suppl; 1989; 549():71-4. PubMed ID: 2784605
[No Abstract] [Full Text] [Related]
10. [Adoptive immunotherapy: a new therapeutic approach to cancer based on interleukin 2].
Sculier JP; Bron D; Delforge A; Stryckmans P; Klastersky J
Rev Med Brux; 1987 Mar; 8(3):133-9. PubMed ID: 3495843
[No Abstract] [Full Text] [Related]
11. Therapy of cancer using the adoptive transfer of activated killer cells and interleukin-2.
Topalian SL; Rosenberg SA
Acta Haematol; 1987; 78 Suppl 1():75-6. PubMed ID: 3124451
[TBL] [Abstract][Full Text] [Related]
12. Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes.
Rosenberg SA; Lotze MT
Annu Rev Immunol; 1986; 4():681-709. PubMed ID: 3518753
[No Abstract] [Full Text] [Related]
13. Adoptive immunotherapy with recombinant interleukin 2, LAK and TIL.
Kurnick JT; Kradin RL
Allergol Immunopathol (Madr); 1991; 19(5):209-14. PubMed ID: 1811418
[No Abstract] [Full Text] [Related]
14. Ex vivo activation and retransfusion of white blood cells. The immunotherapy of cancer.
Hamblin TJ
Curr Stud Hematol Blood Transfus; 1990; (57):249-66. PubMed ID: 2272205
[No Abstract] [Full Text] [Related]
15. Results of clinical trials with the administration of interleukin 2 and adoptive immunotherapy with activated cells in patients with cancer.
Lotze MT; Rosenberg SA
Immunobiology; 1986 Sep; 172(3-5):420-37. PubMed ID: 3100435
[TBL] [Abstract][Full Text] [Related]
16. [Induction of tumoricidal effectors from the tumor-bearer's splenocytes and the prospects of their utilization for adoptive immunotherapy].
Takagi H; Okuno K; Nakamura T; Kokudo S; Iwasa Z; Yasutomi M
Nihon Gan Chiryo Gakkai Shi; 1986 May; 21(4):721-7. PubMed ID: 3489799
[No Abstract] [Full Text] [Related]
17. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes.
Melief CJ
Adv Cancer Res; 1992; 58():143-75. PubMed ID: 1532109
[No Abstract] [Full Text] [Related]
18. Interleukin 2 in cancer therapy.
Testa U; Montesoro E; Bulgarini D; Samoggia P; Masciulli R; Habetswallner D; Carè A; Mariani G; Giannella G; Boccoli G
Ann Ist Super Sanita; 1990; 26(3-4):283-334. PubMed ID: 2091501
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of malignant tumors by interleukin 2 and LAK cells].
Degos L
Nouv Rev Fr Hematol (1978); 1988; 30(1-2):119-22. PubMed ID: 3260373
[TBL] [Abstract][Full Text] [Related]
20. Adoptive immunotherapy in the treatment of malignant disease.
Klein HG; Leitman SF
Transfusion; 1989 Feb; 29(2):170-8. PubMed ID: 2645696
[No Abstract] [Full Text] [Related]
[Next] [New Search]
